Funding Round attributes
OneSkin, a company at the forefront of skin longevity research, has successfully closed a Series A funding round, raising a significant amount to accelerate its mission of revolutionizing the skincare industry. The company focuses on developing innovative solutions that aim to address the biological aspects of skin aging, leveraging cutting-edge science to extend skin vitality and health.
The Series A funding round was led by prominent investors, including Bridgescale Partners, Lerer Hippeau, and Wealthspring Capital. The round also saw participation from a number of notable angel investors, signaling strong market interest in OneSkin's approach to skin health. The company plans to use the raised capital to fuel the continued development of its technology and expand its product offerings.
OneSkin was founded with the goal of using advanced scientific research to develop skincare solutions that go beyond superficial treatments. The company’s focus is on addressing the root causes of skin aging, particularly the role of cellular senescence — a process in which skin cells lose their ability to function optimally. OneSkin aims to promote skin rejuvenation through products that target the skin’s cellular structure, helping to improve skin health and longevity over time.
The company’s flagship product is based on proprietary research into the biology of aging, specifically targeting the skin's extracellular matrix and skin cells. This product utilizes advanced bioengineering and technology to help reduce visible signs of aging by rejuvenating the skin at a cellular level. The Series A funding will enable OneSkin to further refine its product development pipeline and advance clinical trials to bring these innovations to market.
With the Series A funding now secured, OneSkin is poised to continue its groundbreaking work on skin longevity and maintain its position as a key player in the emerging field of skin health biotechnology. The company’s ongoing research and product development will be closely watched by industry experts and consumers alike, as it seeks to redefine what is possible in the fight against skin aging.
